Place an order request to the broker. The personal manager will contact you to confirm the order.

Order Summary

Asset: Select instrument
Quantity: -
Price per Unit: ? This price is indicative and shown for informational purposes only. The final execution price may change. -
Total Amount: -

Order Expiration

Order remains active until you cancel it or it gets filled

Order expires at the end of the selected day

Order Placed Successfully

Your order has been submitted! Our team will contact you shortly to confirm.

Order Type: -
Asset: -
Quantity: -
Total Amount: -
Manually record a past trade to keep your portfolio up to date. This helps track your P&L accurately.
Total Amount: $0.00

Trade Added Successfully

Trade recorded! Your portfolio data will be recalculated.

Type: -
Asset: -
Quantity: -
Price: -
Total: -

Chat Options

Web Search
Search the internet for recent information
Portfolio Context
Include your portfolio in the conversation
Market Data
Access real-time market information
Watchlist Context
Include your watchlist companies

BANCO SANTANDER S.A. (SAN)

2026-06-18T06:35:17.184482+00:00

SAN has pulled back -2.84% to $13.33 following the rapid three-session rally from below $12.21 to $13.72, with the decline representing a technical consolidation rather than a fundamental reversal as the tender offer completion reinforces the capital-optimization narrative.

Key Updates

Since the June 17 report, SAN has retraced -2.84% from $13.72 to $13.33. This decline follows a sharp recovery sequence—+10.23% on June 16, +2.17% later that day, and +2.20% on June 17—that lifted the stock from below the $12.21 support level to a fresh near-term high. The only new corporate development since the last report is the completion of Santander's tender offer for its 4.750% AT1 securities, which settled on June 11, 2026. This event was already partially anticipated in prior sessions and does not alter the underlying operational trajectory.

Current Trend

The year-to-date gain stands at +13.64%, with the one-month return at +12.39% and the six-month return at +15.31%. The five-day performance remains strongly positive at +11.83%, confirming that the intermediate trend is intact despite the latest pullback. The stock has transitioned from a breakdown below $12.21 to a sustained position above the $13.00 threshold, now consolidating near $13.33.

Investment Thesis

The thesis rests on Santander's disciplined capital management and active balance-sheet optimization. The partial repurchase of higher-coupon AT1 securities and the planned €3.3 billion significant risk transfer (SRT) transaction demonstrate management's focus on improving capital efficiency and mitigating portfolio credit risk without divesting core loan assets. These actions support underlying equity value by reducing expensive funding layers and freeing regulatory capital.

Thesis Status

The investment thesis remains valid. The -2.84% pullback is consistent with profit-taking after a +15% five-day advance and does not invalidate the recovery structure above $13.00. The tender offer completion removes near-term event risk and confirms execution on previously communicated capital management priorities. No new adverse factors have emerged.

Key Drivers

Primary catalysts remain the completion of the $850 million AT1 tender offer, of which $701.6 million was accepted and will be cancelled, reducing outstanding hybrid capital PR Newswire. Additionally, the planned SRT tied to approximately €3.3 billion of global corporate loans provides capital relief and reflects robust investor appetite for Santander-originated credit risk Bloomberg Business.

Technical Analysis

Price action shows a -2.84% retracement from the $13.72 recent high to $13.33, with an incremental -0.37% on the current session suggesting moderation in selling pressure. The $13.00 level, previously resistance, now functions as immediate support. The $12.21 level remains the critical structural floor. The sequence of higher highs and higher lows over the past five sessions remains intact provided $13.00 holds on a closing basis.

Bull Case

  • Active liability management via the $701.6 million AT1 tender acceptance directly reduces expensive non-cumulative perpetual preferred capital, improving the cost of capital and equity accretion over time. PR Newswire
  • The €3.3 billion SRT transaction allows Santander to transfer credit risk to external investors while retaining loans on balance sheet, delivering regulatory capital relief and supporting CET1 ratio improvement without sacrificing net interest income. Bloomberg Business
  • The tender offer was oversubscribed in terms of participation relative to the maximum amount, indicating strong investor confidence in Santander's credit profile and willingness to participate in liability management exercises. PR Newswire
  • YTD performance of +13.64% and one-month performance of +12.39% reflect robust demand for the stock and validate the market's positive reassessment of Santander's capital and risk management trajectory. PR Newswire
  • The SRT issuance capitalizes on strong current investor demand for risk transfer instruments, suggesting favorable execution terms and reinforcing Santander's access to alternative capital markets. Bloomberg Business

Bear Case

  • The SRT is tied to a €3.3 billion global corporate loan portfolio; any underlying credit deterioration in these exposures could reduce the economic benefit of the risk transfer or trigger mark-to-market volatility. Bloomberg Business
  • Despite the tender acceptance, $298.4 million of the 4.750% AT1 securities remain outstanding, leaving a residual layer of higher-cost hybrid capital that continues to weigh on capital efficiency. PR Newswire
  • The rapid +15% five-day advance and +12.39% one-month move may have compressed near-term valuation upside and increased the probability of technical profit-taking, as evidenced by the current -2.84% pullback. Bloomberg Business
  • AT1 securities carry contingent conversion and loss-absorption features; the decision to repurchase them may imply management's assessment that all-in funding costs or regulatory treatment of these instruments is becoming less favorable. PR Newswire
  • The SRT transaction is still in structuring and marketing phases with terms ongoing, introducing execution risk and uncertainty regarding the final quantum of capital relief achieved. Bloomberg Business

CapPilot is AI-powered and can make mistakes. Please double-check responses.

CapPilot leverages generative AI to distill market insights and analysis, as well as answer your questions in chat. While we work hard to ensure accuracy, AI-generated content may occasionally contain inaccuracies or outdated information.

We value your feedback — reporting errors helps us continuously improve.